Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 769 to 780 of 797 entries
Sorted by: Best Match Show Resources per page
Innervation and Neuronal Control of the Mammalian Sinoatrial Node a Comprehensive Atlas.

Circulation research

Hanna P, Dacey MJ, Brennan J, Moss A, Robbins S, Achanta S, Biscola NP, Swid MA, Rajendran PS, Mori S, Hadaya JE, Smith EH, Peirce SG, Chen J, Havton LA, Cheng ZJ, Vadigepalli R, Schwaber J, Lux RL, Efimov I, Tompkins JD, Hoover DB, Ardell JL, Shivkumar K.
PMID: 33629877
Circ Res. 2021 Apr 30;128(9):1279-1296. doi: 10.1161/CIRCRESAHA.120.318458. Epub 2021 Feb 25.

[Figure: see text].

Cite
Hanna P, Dacey MJ, Brennan J, et al. Innervation and Neuronal Control of the Mammalian Sinoatrial Node a Comprehensive Atlas. Circ Res. 2021;128(9):1279-1296doi: 10.1161/CIRCRESAHA.120.318458.
Hanna, P., Dacey, M. J., Brennan, J., Moss, A., Robbins, S., Achanta, S., Biscola, N. P., Swid, M. A., Rajendran, P. S., Mori, S., Hadaya, J. E., Smith, E. H., Peirce, S. G., Chen, J., Havton, L. A., Cheng, Z. J., Vadigepalli, R., Schwaber, J., Lux, R. L., Efimov, I., Tompkins, J. D., Hoover, D. B., Ardell, J. L., & Shivkumar, K. (2021). Innervation and Neuronal Control of the Mammalian Sinoatrial Node a Comprehensive Atlas. Circulation research, 128(9), 1279-1296. https://doi.org/10.1161/CIRCRESAHA.120.318458
Hanna, Peter, et al. "Innervation and Neuronal Control of the Mammalian Sinoatrial Node a Comprehensive Atlas." Circulation research vol. 128,9 (2021): 1279-1296. doi: https://doi.org/10.1161/CIRCRESAHA.120.318458
Hanna P, Dacey MJ, Brennan J, Moss A, Robbins S, Achanta S, Biscola NP, Swid MA, Rajendran PS, Mori S, Hadaya JE, Smith EH, Peirce SG, Chen J, Havton LA, Cheng ZJ, Vadigepalli R, Schwaber J, Lux RL, Efimov I, Tompkins JD, Hoover DB, Ardell JL, Shivkumar K. Innervation and Neuronal Control of the Mammalian Sinoatrial Node a Comprehensive Atlas. Circ Res. 2021 Apr 30;128(9):1279-1296. doi: 10.1161/CIRCRESAHA.120.318458. Epub 2021 Feb 25. PMID: 33629877; PMCID: PMC8284939.
Copy Download .nbib Format: NLM
Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure.

Circulation research

Soetkamp D, Gallet R, Parker SJ, Holewinski R, Venkatraman V, Peck K, Goldhaber JI, Marbán E, Van Eyk JE.
PMID: 34641704
Circ Res. 2021 Dec 03;129(12):1125-1140. doi: 10.1161/CIRCRESAHA.119.316311. Epub 2021 Oct 13.

RATIONALE: Phosphorylation of sarcomeric proteins has been implicated in heart failure with preserved ejection fraction (HFpEF); such changes may contribute to diastolic dysfunction by altering contractility, cardiac stiffness, CaOBJECTIVE: Phosphorylation changes that underlie HFpEF and those reversed by CDC...

Cite
Soetkamp D, Gallet R, Parker SJ, et al. Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure. Circ Res. 2021;129(12):1125-1140doi: 10.1161/CIRCRESAHA.119.316311.
Soetkamp, D., Gallet, R., Parker, S. J., Holewinski, R., Venkatraman, V., Peck, K., Goldhaber, J. I., Marbán, E., & Van Eyk, J. E. (2021). Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure. Circulation research, 129(12), 1125-1140. https://doi.org/10.1161/CIRCRESAHA.119.316311
Soetkamp, Daniel, et al. "Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure." Circulation research vol. 129,12 (2021): 1125-1140. doi: https://doi.org/10.1161/CIRCRESAHA.119.316311
Soetkamp D, Gallet R, Parker SJ, Holewinski R, Venkatraman V, Peck K, Goldhaber JI, Marbán E, Van Eyk JE. Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure. Circ Res. 2021 Dec 03;129(12):1125-1140. doi: 10.1161/CIRCRESAHA.119.316311. Epub 2021 Oct 13. PMID: 34641704; PMCID: PMC8666591.
Copy Download .nbib Format: NLM
Inflame on!: mitochondrial escape provokes cytokine storms that doom the heart.

Circulation research

Dorn GW.
PMID: 22821906
Circ Res. 2012 Jul 20;111(3):271-3. doi: 10.1161/CIRCRESAHA.112.275867.

Mitochondria are derived from primordial bacterial endosymbionts and retain partial genomes. In mammalian cells, damaged or dysfunctional mitochondria are recognized, targeted for elimination, then neatly packaged and eliminated via mitophagy. A recent paper from Oka et al describes how...

Cite
Dorn GW. Inflame on!: mitochondrial escape provokes cytokine storms that doom the heart. Circ Res. 2012;111(3):271-3doi: 10.1161/CIRCRESAHA.112.275867.
Dorn, G. W. (2012). Inflame on!: mitochondrial escape provokes cytokine storms that doom the heart. Circulation research, 111(3), 271-3. https://doi.org/10.1161/CIRCRESAHA.112.275867
Dorn, Gerald W. "Inflame on!: mitochondrial escape provokes cytokine storms that doom the heart." Circulation research vol. 111,3 (2012): 271-3. doi: https://doi.org/10.1161/CIRCRESAHA.112.275867
Dorn GW. Inflame on!: mitochondrial escape provokes cytokine storms that doom the heart. Circ Res. 2012 Jul 20;111(3):271-3. doi: 10.1161/CIRCRESAHA.112.275867. PMID: 22821906.
Copy Download .nbib Format: NLM
Antibodies to PCSK9: a superior way to lower LDL cholesterol?.

Circulation research

Maxwell KN, Breslow JL.
PMID: 22821907
Circ Res. 2012 Jul 20;111(3):274-7. doi: 10.1161/CIRCRESAHA.112.275859.

Lowering of LDL cholesterol, predominantly accomplished clinically by statins, is one of the key components of both the prevention and medical management of coronary atherosclerosis; however, additional or alternative cholesterol lowering agents are needed for patients who fail to...

Cite
Maxwell KN, Breslow JL. Antibodies to PCSK9: a superior way to lower LDL cholesterol?. Circ Res. 2012;111(3):274-7doi: 10.1161/CIRCRESAHA.112.275859.
Maxwell, K. N., & Breslow, J. L. (2012). Antibodies to PCSK9: a superior way to lower LDL cholesterol?. Circulation research, 111(3), 274-7. https://doi.org/10.1161/CIRCRESAHA.112.275859
Maxwell, Kara N, and Breslow, Jan L. "Antibodies to PCSK9: a superior way to lower LDL cholesterol?." Circulation research vol. 111,3 (2012): 274-7. doi: https://doi.org/10.1161/CIRCRESAHA.112.275859
Maxwell KN, Breslow JL. Antibodies to PCSK9: a superior way to lower LDL cholesterol?. Circ Res. 2012 Jul 20;111(3):274-7. doi: 10.1161/CIRCRESAHA.112.275859. PMID: 22821907.
Copy Download .nbib Format: NLM
PRMT5 Prevents Dilated Cardiomyopathy via Suppression of Protein O-GlcNAcylation.

Circulation research

Li Z, Xu J, Song Y, Xin C, Liu L, Hou N, Teng Y, Cheng X, Wang T, Yu Z, Song J, Zhang Y, Wang J, Yang X.
PMID: 34503365
Circ Res. 2021 Oct 15;129(9):857-871. doi: 10.1161/CIRCRESAHA.121.319456. Epub 2021 Sep 10.

[Figure: see text].

Cite
Li Z, Xu J, Song Y, et al. PRMT5 Prevents Dilated Cardiomyopathy via Suppression of Protein O-GlcNAcylation. Circ Res. 2021;129(9):857-871doi: 10.1161/CIRCRESAHA.121.319456.
Li, Z., Xu, J., Song, Y., Xin, C., Liu, L., Hou, N., Teng, Y., Cheng, X., Wang, T., Yu, Z., Song, J., Zhang, Y., Wang, J., & Yang, X. (2021). PRMT5 Prevents Dilated Cardiomyopathy via Suppression of Protein O-GlcNAcylation. Circulation research, 129(9), 857-871. https://doi.org/10.1161/CIRCRESAHA.121.319456
Li, Zhenhua, et al. "PRMT5 Prevents Dilated Cardiomyopathy via Suppression of Protein O-GlcNAcylation." Circulation research vol. 129,9 (2021): 857-871. doi: https://doi.org/10.1161/CIRCRESAHA.121.319456
Li Z, Xu J, Song Y, Xin C, Liu L, Hou N, Teng Y, Cheng X, Wang T, Yu Z, Song J, Zhang Y, Wang J, Yang X. PRMT5 Prevents Dilated Cardiomyopathy via Suppression of Protein O-GlcNAcylation. Circ Res. 2021 Oct 15;129(9):857-871. doi: 10.1161/CIRCRESAHA.121.319456. Epub 2021 Sep 10. PMID: 34503365.
Copy Download .nbib Format: NLM
Phosphodiesterase 5: A Novel Therapeutic Target in Long QT Syndrome.

Circulation research

Zaza A, Lodola F.
PMID: 34473532
Circ Res. 2021 Sep 03;129(6):666-668. doi: 10.1161/CIRCRESAHA.121.319851. Epub 2021 Sep 02.

No abstract available.

Cite
Zaza A, Lodola F. Phosphodiesterase 5: A Novel Therapeutic Target in Long QT Syndrome. Circ Res. 2021;129(6):666-668doi: 10.1161/CIRCRESAHA.121.319851.
Zaza, A., & Lodola, F. (2021). Phosphodiesterase 5: A Novel Therapeutic Target in Long QT Syndrome. Circulation research, 129(6), 666-668. https://doi.org/10.1161/CIRCRESAHA.121.319851
Zaza, Antonio, and Lodola, Francesco. "Phosphodiesterase 5: A Novel Therapeutic Target in Long QT Syndrome." Circulation research vol. 129,6 (2021): 666-668. doi: https://doi.org/10.1161/CIRCRESAHA.121.319851
Zaza A, Lodola F. Phosphodiesterase 5: A Novel Therapeutic Target in Long QT Syndrome. Circ Res. 2021 Sep 03;129(6):666-668. doi: 10.1161/CIRCRESAHA.121.319851. Epub 2021 Sep 02. PMID: 34473532.
Copy Download .nbib Format: NLM
N-Acetyl Transferases: New Insights Into Human Congenital Cardiovascular Defects.

Circulation research

Cashman TJ, Trivedi CM.
PMID: 33856919
Circ Res. 2021 Apr 16;128(8):1170-1172. doi: 10.1161/CIRCRESAHA.121.319049. Epub 2021 Apr 15.

No abstract available.

Cite
Cashman TJ, Trivedi CM. N-Acetyl Transferases: New Insights Into Human Congenital Cardiovascular Defects. Circ Res. 2021;128(8):1170-1172doi: 10.1161/CIRCRESAHA.121.319049.
Cashman, T. J., & Trivedi, C. M. (2021). N-Acetyl Transferases: New Insights Into Human Congenital Cardiovascular Defects. Circulation research, 128(8), 1170-1172. https://doi.org/10.1161/CIRCRESAHA.121.319049
Cashman, Timothy J, and Trivedi, Chinmay M. "N-Acetyl Transferases: New Insights Into Human Congenital Cardiovascular Defects." Circulation research vol. 128,8 (2021): 1170-1172. doi: https://doi.org/10.1161/CIRCRESAHA.121.319049
Cashman TJ, Trivedi CM. N-Acetyl Transferases: New Insights Into Human Congenital Cardiovascular Defects. Circ Res. 2021 Apr 16;128(8):1170-1172. doi: 10.1161/CIRCRESAHA.121.319049. Epub 2021 Apr 15. PMID: 33856919; PMCID: PMC8054922.
Copy Download .nbib Format: NLM
Gut Dysbiosis-Induced Hypertension Is Ameliorated by Intermittent Fasting.

Circulation research

Touyz RM.
PMID: 33914600
Circ Res. 2021 Apr 30;128(9):1255-1257. doi: 10.1161/CIRCRESAHA.121.319147. Epub 2021 Apr 29.

No abstract available.

Cite
Touyz RM. Gut Dysbiosis-Induced Hypertension Is Ameliorated by Intermittent Fasting. Circ Res. 2021;128(9):1255-1257doi: 10.1161/CIRCRESAHA.121.319147.
Touyz, R. M. (2021). Gut Dysbiosis-Induced Hypertension Is Ameliorated by Intermittent Fasting. Circulation research, 128(9), 1255-1257. https://doi.org/10.1161/CIRCRESAHA.121.319147
Touyz, Rhian M. "Gut Dysbiosis-Induced Hypertension Is Ameliorated by Intermittent Fasting." Circulation research vol. 128,9 (2021): 1255-1257. doi: https://doi.org/10.1161/CIRCRESAHA.121.319147
Touyz RM. Gut Dysbiosis-Induced Hypertension Is Ameliorated by Intermittent Fasting. Circ Res. 2021 Apr 30;128(9):1255-1257. doi: 10.1161/CIRCRESAHA.121.319147. Epub 2021 Apr 29. PMID: 33914600.
Copy Download .nbib Format: NLM
A Compendium on Hypertension: New Advances and Future Impact.

Circulation research

Touyz RM, Schiffrin EL.
PMID: 33793329
Circ Res. 2021 Apr 02;128(7):803-807. doi: 10.1161/CIRCRESAHA.121.319181. Epub 2021 Apr 01.

No abstract available.

Cite
Touyz RM, Schiffrin EL. A Compendium on Hypertension: New Advances and Future Impact. Circ Res. 2021;128(7):803-807doi: 10.1161/CIRCRESAHA.121.319181.
Touyz, R. M., & Schiffrin, E. L. (2021). A Compendium on Hypertension: New Advances and Future Impact. Circulation research, 128(7), 803-807. https://doi.org/10.1161/CIRCRESAHA.121.319181
Touyz, Rhian M, and Schiffrin, Ernesto L. "A Compendium on Hypertension: New Advances and Future Impact." Circulation research vol. 128,7 (2021): 803-807. doi: https://doi.org/10.1161/CIRCRESAHA.121.319181
Touyz RM, Schiffrin EL. A Compendium on Hypertension: New Advances and Future Impact. Circ Res. 2021 Apr 02;128(7):803-807. doi: 10.1161/CIRCRESAHA.121.319181. Epub 2021 Apr 01. PMID: 33793329.
Copy Download .nbib Format: NLM
Device Therapy of Hypertension.

Circulation research

Mahfoud F, Schlaich MP, Lobo MD.
PMID: 33793330
Circ Res. 2021 Apr 02;128(7):1080-1099. doi: 10.1161/CIRCRESAHA.121.318091. Epub 2021 Apr 01.

In the past decade, efforts to improve blood pressure control have looked beyond conventional approaches of lifestyle modification and drug therapy to embrace interventional therapies. Based upon animal and human studies clearly demonstrating a key role for the sympathetic...

Cite
Mahfoud F, Schlaich MP, Lobo MD. Device Therapy of Hypertension. Circ Res. 2021;128(7):1080-1099doi: 10.1161/CIRCRESAHA.121.318091.
Mahfoud, F., Schlaich, M. P., & Lobo, M. D. (2021). Device Therapy of Hypertension. Circulation research, 128(7), 1080-1099. https://doi.org/10.1161/CIRCRESAHA.121.318091
Mahfoud, Felix, et al. "Device Therapy of Hypertension." Circulation research vol. 128,7 (2021): 1080-1099. doi: https://doi.org/10.1161/CIRCRESAHA.121.318091
Mahfoud F, Schlaich MP, Lobo MD. Device Therapy of Hypertension. Circ Res. 2021 Apr 02;128(7):1080-1099. doi: 10.1161/CIRCRESAHA.121.318091. Epub 2021 Apr 01. PMID: 33793330.
Copy Download .nbib Format: NLM
Pathophysiology of Hypertension: The Mosaic Theory and Beyond.

Circulation research

Harrison DG, Coffman TM, Wilcox CS.
PMID: 33793328
Circ Res. 2021 Apr 02;128(7):847-863. doi: 10.1161/CIRCRESAHA.121.318082. Epub 2021 Apr 01.

Dr Irvine Page proposed the Mosaic Theory of Hypertension in the 1940s advocating that hypertension is the result of many factors that interact to raise blood pressure and cause end-organ damage. Over the years, Dr Page modified his paradigm,...

Cite
Harrison DG, Coffman TM, Wilcox CS. Pathophysiology of Hypertension: The Mosaic Theory and Beyond. Circ Res. 2021;128(7):847-863doi: 10.1161/CIRCRESAHA.121.318082.
Harrison, D. G., Coffman, T. M., & Wilcox, C. S. (2021). Pathophysiology of Hypertension: The Mosaic Theory and Beyond. Circulation research, 128(7), 847-863. https://doi.org/10.1161/CIRCRESAHA.121.318082
Harrison, David G, et al. "Pathophysiology of Hypertension: The Mosaic Theory and Beyond." Circulation research vol. 128,7 (2021): 847-863. doi: https://doi.org/10.1161/CIRCRESAHA.121.318082
Harrison DG, Coffman TM, Wilcox CS. Pathophysiology of Hypertension: The Mosaic Theory and Beyond. Circ Res. 2021 Apr 02;128(7):847-863. doi: 10.1161/CIRCRESAHA.121.318082. Epub 2021 Apr 01. PMID: 33793328; PMCID: PMC8023760.
Copy Download .nbib Format: NLM
Vascular Stress Signaling in Hypertension.

Circulation research

Cicalese SM, da Silva JF, Priviero F, Webb RC, Eguchi S, Tostes RC.
PMID: 33793333
Circ Res. 2021 Apr 02;128(7):969-992. doi: 10.1161/CIRCRESAHA.121.318053. Epub 2021 Apr 01.

Cells respond to stress by activating a variety of defense signaling pathways, including cell survival and cell death pathways. Although cell survival signaling helps the cell to recover from acute insults, cell death or senescence pathways induced by chronic...

Cite
Cicalese SM, da Silva JF, Priviero F, et al. Vascular Stress Signaling in Hypertension. Circ Res. 2021;128(7):969-992doi: 10.1161/CIRCRESAHA.121.318053.
Cicalese, S. M., da Silva, J. F., Priviero, F., Webb, R. C., Eguchi, S., & Tostes, R. C. (2021). Vascular Stress Signaling in Hypertension. Circulation research, 128(7), 969-992. https://doi.org/10.1161/CIRCRESAHA.121.318053
Cicalese, Stephanie M, et al. "Vascular Stress Signaling in Hypertension." Circulation research vol. 128,7 (2021): 969-992. doi: https://doi.org/10.1161/CIRCRESAHA.121.318053
Cicalese SM, da Silva JF, Priviero F, Webb RC, Eguchi S, Tostes RC. Vascular Stress Signaling in Hypertension. Circ Res. 2021 Apr 02;128(7):969-992. doi: 10.1161/CIRCRESAHA.121.318053. Epub 2021 Apr 01. PMID: 33793333; PMCID: PMC8023761.
Copy Download .nbib Format: NLM
Showing 769 to 780 of 797 entries